LIGAND-BINDING POLYPEPTIDES AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240327495A1
SERIAL NO

18267189

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to polypeptides that are resistant to degradation in the gastrointestinal tract and that bind to a target (i.e. a target ligand). In particular, it provides a mutant Kunitz-type soybean trypsin inhibitor (SBTI) family polypeptide comprising two or more amino acid mutations compared to the corresponding unmutated (e.g. wild-type) SBTI family polypeptide, wherein the mutant SBTI family polypeptide comprises: (i) one or more amino acid mutations in a first domain corresponding to positions 22-25 of SEQ ID NO: 1; and (ii) one or more amino acid mutations in a second domain corresponding to positions 47-50 of SEQ ID NO: 1, wherein the mutant SBTI family polypeptide: (a) binds selectively to a ligand that does not bind to the corresponding unmutated (e.g. wild-type) SBTI family polypeptide; and (b) is resistant to cleavage by pepsin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CAMBRIDGE ENTERPRISE LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB2 1TN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HOWARTH, Mark Oxford, Oxfordshire, GB 17 63
WICKE, Niels London, Greater London, GB 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation